Molecular Alterations in Basal Cell Carcinoma Subtypes
Lucia Di Nardo(Università Cattolica del Sacro Cuore), Ketty Peris(Agostino Gemelli University Polyclinic), Cristina Pellegrini(University of L'Aquila), Vincenzo Corbo(University of Verona), Alessandro Di Stefani(University of Rome Tor Vergata), Simona De Summa(Istituto Tumori Bari), Geny Piro(University of Verona), Giampaolo Tortora(University of Naples Federico II), Maria Concetta Fargnoli(University of L'Aquila), Francesco Ricci(Istituto Dermopatico dell'Immacolata), Maria Giovanna Maturo(University of L'Aquila), Barbara Fossati(IRCCS Policlinico San Donato), Pietro Delfino(University of Verona), Carmine Carbone(Agostino Gemelli University Polyclinic), Tea Rocco(University of L'Aquila), Laura Del Regno(Agostino Gemelli University Polyclinic)
Cited by 1
Related Papers
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709
Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*
|British Journal of Dermatology|2020|590
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589